- Sibutramine
- Sibutramine hydrochloride anhydrous
- Sibutramine hydrochloride monohydrate
- 1066-50-8Phosphonic dichloride,P-ethyl-
- 1066-51-9Phosphonic acid,P-(aminomethyl)-
- 1066-54-2Trimethylsilylacetylene
- 106658-09-72-Propan-1,1,1,2,3,3,3-d7-amine(9CI)
- 106658-10-02-Propan-1,1,1,2,3,3,3-d7-amine,hydrochloride (9CI)
- 106670-34-2Ethanamine,2-[[(4-methylphenyl)methyl]thio]-
- 106681-15-6Ruthenium, bis(acetato-kO,kO')[1,1'-(1S)-[1,1'-binaphthalene]-2,2'-diylbis[1,1-bis(4-methylphenyl)phosphine-kP]]-, (OC-6-22)-
- 106-68-33-Octanone
- 106685-40-9Adapalene
- 106685-41-02-Naphthalenecarboxylicacid, 6-(4-methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-, methyl ester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
| Name |
Sibutramine |
EINECS | N/A |
| CAS No. | 106650-56-0 | Density | 1.031 g/cm3 |
| PSA | 3.24000 | LogP | 4.73800 |
| Solubility | Water solubility: 2.9 mg/mL | Melting Point |
191-192 °C |
| Formula | C17H26ClN | Boiling Point | 342.6 °C at 760 mmHg |
| Molecular Weight | 279.853 | Flash Point | 161 °C |
| Transport Information | 25kgs | Appearance | Yellowish solid |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
UNII-WV5EC51866;Didemethylsibutramine hydrochloride;Medaria;Racemic sibutramine; |
Article Data | 18 |
Sibutramine Chemical Properties
Molecular Structure:
Molecular Formula: C17H26ClN
Molecular Weight: 279.848
IUPAC Name: 1-[1-(4-Chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine
Synonyms of Sibutramine (CAS NO.106650-56-0): Sibutramine [INN:BAN] ; Medaria ; Reductil ; Sibutramina ; Sibutramina [Spanish] ; Sibutraminum ; Sibutraminum [Latin] ; UNII-WV5EC51866 ; Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)- ; DEA No. 1675
CAS NO: 106650-56-0
Classification Code: Anti-Obesity Agents ; Antidepressive agents ; Appetite depressants ; Central Nervous System Agents ; Psychotropic Drugs
Melting point: 191-192°C
Index of Refraction: 1.529
Molar Refractivity: 83.76 cm3
Molar Volume: 271.3 cm3
Surface Tension: 37.3 dyne/cm
Density: 1.031 g/cm3
Flash Point: 161 °C
Enthalpy of Vaporization: 58.64 kJ/mol
Boiling Point: 342.6 °C at 760 mmHg
Vapour Pressure: 7.45E-05 mmHg at 25°C
Sibutramine Uses
Sibutramine (CAS NO.106650-56-0) has been used as an appetite suppressant administered orally for the treatment of obesity.
Sibutramine Specification
Sibutramine (CAS NO.106650-56-0) is a centrally-acting serotonin-norepinephrine reuptake inhibitor structurally related to amphetamines, and is also under review by the FDA and the European Medicines Agency. It is classified as a Schedule IV controlled substance in the United States, despite having virtually no potential for misuse due to its lack of appreciable dopaminergic effects. As a neurotransmitter reuptake inhibitor, it reduces the reuptake of serotonin (by 53%), norepinephrine (by 54%), and dopamine (by 16%), thereby increasing the levels of these substances in synaptic clefts and helping enhance satiety. It has a number of clinically significant interactions, and a higher number of cardiovascular events has been observed in people taking it verses control (11.4% vs. 10.0%).